001     840339
005     20220930130137.0
024 7 _ |a 10.1002/jlcr.3578
|2 doi
024 7 _ |a 0022-2135
|2 ISSN
024 7 _ |a 0362-4803
|2 ISSN
024 7 _ |a 1099-1344
|2 ISSN
024 7 _ |a pmid:29110328
|2 pmid
024 7 _ |a WOS:000428647600003
|2 WOS
037 _ _ |a FZJ-2017-07881
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Spahn, Ingo
|0 P:(DE-Juel1)131849
|b 0
245 _ _ |a Development of novel radionuclides for medical applications
260 _ _ |a New York, NY [u.a.]
|c 2018
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1526461727_22448
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Medical radionuclide production technology is well established. There is, however, a constant need for further development of radionuclides. The present efforts are mainly devoted to non-standard positron emitters (e.g. 64Cu, 86Y, 124I, 73Se) and novel therapeutic radionuclides emitting low-range β- particles (e. g. 67Cu, 186Re), conversion or Auger electrons (e.g. 117mSn, 77Br) and α-particles (e.g. 225Ac). A brief account of various aspects of development work (i.e. nuclear data, targetry, chemical processing, quality control) is given. For each radionuclide under consideration the status of technology for clinical scale production is discussed. The increasing need of intermediate-energy multiple-particle accelerating cyclotrons is pointed out.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Qaim, Syed M.
|0 P:(DE-Juel1)131840
|b 1
|e Corresponding author
773 _ _ |a 10.1002/jlcr.3578
|0 PERI:(DE-600)1491841-9
|p 126-140
|t Journal of labelled compounds and radiopharmaceuticals
|v 61
|y 2018
|x 0362-4803
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/840339/files/Qaim_et_al-2018-Journal_of_Labelled_Compounds_and_Radiopharmaceuticals.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:840339
|p VDB
|p openCost
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131849
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131840
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J LABELLED COMPD RAD : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a APC
980 _ _ |a UNRESTRICTED
980 1 _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21